ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NRIX Nurix Therapeutics Inc

18.41
3.12 (20.41%)
Last Updated: 14:55:45
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Nurix Therapeutics Inc NRIX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
3.12 20.41% 18.41 14:55:45
Open Price Low Price High Price Close Price Previous Close
16.38 15.34 18.8999 15.29
more quote information »

Recent News

Date Time Source Heading
6/17/202406:02EDGAR2Form 8-K - Current report
6/16/202404:30GLOBENurix Therapeutics Presents Positive Results from Ongoing..
6/13/202417:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/12/202418:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/11/202415:06EDGAR2Form S-3ASR - Automatic shelf registration statement of..
6/10/202406:00GLOBENurix Therapeutics to Host a Webcast and Conference Call to..
6/05/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/03/202417:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/03/202415:58EDGAR2Form 144 - Report of proposed sale of securities
5/29/202406:00GLOBENurix Therapeutics to Participate in the Jefferies Global..
5/28/202406:00GLOBENurix Therapeutics Appoints Paula G. O’Connor, M.D., as..
5/21/202406:06EDGAR2Form 8-K - Current report
5/20/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/20/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/20/202415:00GLOBENurix Therapeutics Announces Board Chair Transition
5/14/202409:00GLOBENurix Therapeutics Announces Upcoming Oral Presentation of..
5/07/202406:00GLOBENurix Therapeutics to Participate in RBC Capital Markets..
4/16/202417:21GLOBENurix Therapeutics Announces Closing of Public Offering and..
4/11/202422:38GLOBENurix Therapeutics Announces Pricing of Upsized $175.0..
4/11/202415:00GLOBENurix Therapeutics Announces Proposed Public Offering
4/10/202406:00GLOBENurix Therapeutics Reports First Quarter Fiscal 2024..
4/09/202412:15GLOBENurix Therapeutics Reports First Clinical Evidence of CNS..
4/09/202406:00GLOBENurix Therapeutics Announces Extension of Strategic..
4/03/202406:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
4/02/202406:00GLOBENurix Therapeutics Announces Extension of Strategic..
3/25/202406:00GLOBENurix Therapeutics is Part of a Team of International..
3/20/202408:40GLOBENurix Presents the Discovery and Chemical Structure of..
3/11/202406:02EDGAR2Form 8-K - Current report
3/11/202406:00GLOBENurix Therapeutics Announces U.S. FDA Lifts Partial Clinical..
3/06/202415:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
3/05/202415:30GLOBENurix Therapeutics Announces Presentations at the American..
2/16/202418:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202415:22EDGAR2Form 144 - Report of proposed sale of securities
2/15/202415:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/15/202415:01EDGAR2Form 8-K - Current report
2/15/202415:00GLOBENurix Therapeutics Reports Fourth Quarter and Fiscal Year..
2/15/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202407:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202415:01GLOBENurix Therapeutics Announces Publication in the Journal..
1/30/202417:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202417:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202417:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202415:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/16/202415:48DJNNurix Therapeutics Gets FDA Fast-Track Designation for..
1/16/202415:01GLOBENurix Therapeutics Receives U.S. FDA Fast Track Designation..
1/08/202406:03EDGAR2Form 8-K - Current report
1/08/202406:00GLOBENurix Therapeutics Outlines 2024 Strategic Priorities with..
1/02/202415:01GLOBENurix Therapeutics to Present at 42nd Annual J.P. Morgan..

Your Recent History

Delayed Upgrade Clock